Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Anyone hear if we are still going to meeting? My RSM says Princeton is finalizing “details” and then travel will re-open for us to book. Last email I rec’d was some people may have to come in earlier or something but rest of us would book next day? Who knows at this point. NOONE WANTS TO GO for...
anonymous
Thread
market access
nsm
sun biologics
sun pharma
tildratildrakizumab
Take this as however you want it but when I was sold the promise of owning my territory, making a difference, and a nice salary to provide for my family I had no idea I was selling my soul to the most incompetent RSM who undermines my every effort, plays favorites, likes to make life hell for...
A bit of advice to senior leadership is keep close watch on a few of your TMs before Sun gets dragged through compliance hell & more bad press. Did I miss part during Hub training call where we can fill out patient enrollment forms for office with patient info, maybe even sign them, and fax in...
DEATH and terrible data, good luck, oh my!
reSURFACE 1, at week 12, a PASI75 was acheived in 62% in the 200 mg group and 64% in the 100 mg group compared with 6% in the placebo group (p<0·0001 vs placebo).
In reSURFACE 2, a PASI75 was seen 66% in the 200 mg group, 61% in the 100 mg group, and...